• 検索結果がありません。

[PDF] Top 20 April 2014 March 2015 Financial Report | IRライブラリー | 株主・投資家の皆様へ | アマノ

Has 10000 "April 2014 March 2015 Financial Report | IRライブラリー | 株主・投資家の皆様へ | アマノ" found on our website. Below are the top 20 most common "April 2014 March 2015 Financial Report | IRライブラリー | 株主・投資家の皆様へ | アマノ".

相模原市と学校法人麻布獣医学園との「災害時における所有者不明動物の救護活動に関する協定」の締結について

alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.

... (1) alpha-NF may inhibit the activation of phospholipase C, followed by inhibition of phosphoinositide breakdown, protein kinase C activation, and thromboxane A(2) formation, thereby l[r] ... 完全なドキュメントを参照

2

Alpha-naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.

Alpha-naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.

... alpha-NF (5 and 10 microM) inhibited intracellular Ca(2+) mobilization, phosphoinositide breakdown, and thromboxane A(2) formation stimulated by collagen (1 microg/mL) in human platele[r] ... 完全なドキュメントを参照

Alpha-naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.

Alpha-naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.

... (1) alpha-NF may inhibit the activation of phospholipase C, followed by inhibition of phosphoinositide breakdown, protein kinase C activation, and thromboxane A(2) formation, thereby l[r] ... 完全なドキュメントを参照

平成29年04月27日 3

α-Naphthoflavone, a Potent Antiplatelet Flavonoid, Is Mediated through Inhibition of Phospholipase C Activity and Stimulation of Cyclic GMP Formation

... (1) α-NF may inhibit the activation of phospholipase C, followed by inhibition of phosphoinositide breakdown, protein kinase C activation, and thromboxane A2 formation, thereby leading[r] ... 完全なドキュメントを参照

4

The Antiplatelet activity of ketamine is mediated through suppression of phosphoinositide breakdown and an increase in cyclic GMP.

The Antiplatelet activity of ketamine is mediated through suppression of phosphoinositide breakdown and an increase in cyclic GMP.

... In this study, Escherichia coli LPS dose-dependently (100-500 μg/ ml) and time- dependently (10-60 min) inhibited platelet aggregation in human and rabbit platelets stimulated by agonis[r] ... 完全なドキュメントを参照

The Antiplatelet activity of ketamine is mediated through suppression of phosphoinositide breakdown and an increase in cyclic GMP.

The Antiplatelet activity of ketamine is mediated through suppression of phosphoinositide breakdown and an increase in cyclic GMP.

... coli LPS may be involved in the activation of a nitric oxide/cyclic GMP pathway in platelets, resulting in inhibition of platelet aggregation. Therefore, LPS-mediated alteration of pla[r] ... 完全なドキュメントを参照

The antiplatelet activity of Escherichia coli lipopolysaccharide is mediated through a nitric oxide/cyclic GMP pathway.

The antiplatelet activity of Escherichia coli lipopolysaccharide is mediated through a nitric oxide/cyclic GMP pathway.

... In this study, Escherichia coli LPS dose-dependently (100-500 μg/ ml) and time- dependently (10-60 min) inhibited platelet aggregation in human and rabbit platelets stimulated by agonis[r] ... 完全なドキュメントを参照

事件・事故、事務処理誤り等の状況(週間提供分)について 発表資料 平成26年5月分 | 相模原市

The antiplatelet activity of escherichia coli lipopolysaccharide is mediated through a nitric oxide/cyclic GMP pathway.

... microg/ml) and time-dependently (10-60 min) inhibited platelet aggregation in human and rabbit platelets stimulated by ...(200 and 500 microg/ml) significantly increased the formation ... 完全なドキュメントを参照

2

The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C.

The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C.

... (50 and 100 mM) dose- bition of phospholipase C activity, leading to redependently inhibited the increase in intracellular duce phosphoinositide breakdown, followed by the free Ca21 ... 完全なドキュメントを参照

The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C.

The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C.

... YM and Yen MH Abstract In this study, the mechanism involved in the anti- affect nitrate production in collagen (10 mg/ml)-platelet activity of rutaecarpine in human platelet induced human platelet ... 完全なドキュメントを参照

相模女子大学及び相模女子大学短期大学部と市が包括連携協定を締結します 発表資料 平成26年5月分 | 相模原市

The antiplatelet activity of rutaecarpine, an alkaloid isolated from evodia rutaecarpa, is mediated through inhibition of phospholipase C.

... It is concluded that the antiplatelet activity of rutaecarpine may possibly be due to the inhibition of phospholipase C activity, leading to reduce phosphoinositide breakdown, followed[r] ... 完全なドキュメントを参照

2

平成25年度 相模原市における児童虐待等の相談状況について 発表資料 平成26年5月分 | 相模原市

Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets.

... The present study reports a novel and potent antiplatelet agent, CAPE, which involved in the following inhibitory pathways: CAPE increases cyclic GMP/VASP Ser157 phosphorylation, and s[r] ... 完全なドキュメントを参照

3

The antiplatelet activity of PMC, a potent a-tocopherol analogue, is mediated through inhibition of cyclooxygenase. Br.

The antiplatelet activity of PMC, a potent a-tocopherol analogue, is mediated through inhibition of cyclooxygenase. Br.

... (10 and 25μM) significantly inhibited collagen-stimulated thromboxane A2 (TxA2) formation in human ...(25 and 100μM) did not increase the formation of cyclic AMP or ... 完全なドキュメントを参照

The antiplatelet activity of PMC, a potent a-tocopherol analogue, is mediated through inhibition of cyclooxygenase. Br.

The antiplatelet activity of PMC, a potent a-tocopherol analogue, is mediated through inhibition of cyclooxygenase. Br.

... (10 and 25μM) significantly inhibited collagen-stimulated thromboxane A2 (TxA2) formation in human ...(25 and 100μM) did not increase the formation of cyclic AMP or ... 完全なドキュメントを参照

シールドマシンがいよいよ発進します 発表資料 平成26年5月分 | 相模原市

Antiplatelet activity of Staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway

... In this study, Gram-positive Staphylococcus aureus lipoteichoic acid (LTA) dose dependently (0.1-1.0 microg/mL) and time dependently (10-60 min) inhibited platelet aggregation in human[r] ... 完全なドキュメントを参照

2

Antiplatelet activity of staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway

Antiplatelet activity of staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway

... CH and Lin CH Abstract In this study, Gram-positive Staphylococcus aureus ence ...mg/mL) and time dependently (10–60 min) inhib- Key Words: Gram-positive bacteria; LTA; Platelet aggreited platelet ... 完全なドキュメントを参照

Antiplatelet activity of staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway

Antiplatelet activity of staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway

... CH and Lin CH Abstract In this study, Gram-positive Staphylococcus aureus ence ...mg/mL) and time dependently (10–60 min) inhib- Key Words: Gram-positive bacteria; LTA; Platelet aggreited platelet ... 完全なドキュメントを参照

工事監査(随時監査)  長野市ホームページ

Antiplatelet Activity of Staphylococcus aureus Lipoteichoic Acid Is Mediated Through a Cyclic AMP Pathway

... In this study, Gram-positive Staphylococcus aureus lipoteichoic acid (LTA) dose dependently (0.1-1.0 microg/mL) and time dependently (10-60 min) inhibited platelet aggregation in human[r] ... 完全なドキュメントを参照

9

The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase.

The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase.

... Furthermore, TMPZ concentration (50 and 200m M)- and time (15 and 30 min)-dependently triggered endothelial- type constitutive nitric oxide synthase (ecNOS) protein expr[r] ... 完全なドキュメントを参照

The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase.

The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase.

... Furthermore, TMPZ concentration (50 and 200m M)- and time (15 and 30 min)-dependently triggered endothelial- type constitutive nitric oxide synthase (ecNOS) protein expression in huma[r] ... 完全なドキュメントを参照

Show all 10000 documents...